Boothbay Fund Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.76M Buy
+271,836
New +$6.36M 0.09% 255
2026
Q1
Sell
-46,920
Closed -$527K 2065
2025
Q4
$527K Buy
+46,920
New +$537K 0.01% 1112
2016
Q3
Sell
-7,474
Closed -$243K 706
2016
Q2
$243K Buy
+7,474
New +$229K 0.09% 312
2015
Q4
Sell
-9,224
Closed -$262K 562
2015
Q3
$262K Buy
+9,224
New +$322K 0.12% 232

Other funds holding AVNS

Boothbay Fund Management's AVNS Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Avanos Medical (AVNS) in Q2 2026: 271,836 shares worth $6.76M. The stake represents 0.09% of the portfolio and ranks #255 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in AVNS as recently as Q4 2025.

Boothbay Fund Management first reported a position in AVNS in Q3 2015 and has held it in 4 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Boothbay Fund Management held 271,836 shares of Avanos Medical worth $6.76M as of Q2 2026.
  • Avanos Medical was a new Boothbay Fund Management position in Q2 2026.
  • Avanos Medical made up 0.09% of Boothbay Fund Management's portfolio in Q2 2026, its #255 holding.
  • Boothbay Fund Management first reported a position in Avanos Medical in Q3 2015 and has held it in 4 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.